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Overview
During July there were a total of 887 fatal and nonfatal overdoses, including 52 (6%) suspected 
and confirmed fatal overdoses in July and 835 (94%) nonfatal overdoses. The proportion of 
fatal overdoses declined slightly from 7% in June to 6% in July.  Deduplicated data derived 
from multiple statewide sources were compiled to reach these totals.  They include nonfatal 
overdose incidents reported by hospital emergency rooms (ED), nonfatal emergency medical 
service (EMS) responses without transport to the ED; overdose reversals reported by law 
enforcement; and overdose reversals reported by community members or agencies receiving 
state-distributed naloxone. There are also an unknown number of private overdose reversals 
that were not reported, and an unknown number of the community-reported reversals that may 
have overlapped with emergency response by EMS or law enforcement. 
Composite Total of Fatal and Nonfatal Overdoses
During July 2021, there were an estimated 887 fatal and nonfatal drug overdoses statewide 
(Figure 1), of which 52 (6%) were suspected and confirmed fatal overdoses. The remaining 830 
(94%) were reported nonfatal overdoses: 449 (51%) nonfatal emergency department visits; 
214 (24%) EMS patients who survived and were not transported to the emergency room; and 
167 (19%) reversals reported by 
community members to the Maine 
Naloxone Distribution Initiative. 
There were also an unknown 
number of nonfatal overdoses for 
which 911 was not called and for which 
no community reversal report was 
provided.
The cumulative number of reported 
fatal and nonfatal overdoses for 
January through July, 5012, is displayed 
in Table 1 in the far right-hand 
column: 360 (7%) fatal overdoses; 
2419 (48%) nonfatal emergency 
department visits; 1220 (24%) nonfatal 
EMS responses not transported to the 
emergency department; 978 (20%) 
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reported community reversals; and an estimated 35 (<1%) law enforcement reversals without 
EMS. As mentioned above, there were additional overdose incidents that were not reported, for 
which the total number is unknown. Additionally, some of the reported community reversals 
may overlap with EMS or law enforcement responses.




















January 55 263 163 127 5 605
February 42 263 117 100 5 523
March 57 399 169 158 5 782
April 47 326 187 139 5 697
May 48 323 157 101 5 626
June 59 396 213 189 5 880
















The July 2021 total of 52 fatal drug overdoses consists of 10 confirmed drug deaths and 42 
suspected drug deaths. Figure 2 shows the considerable monthly fluctuation of deaths since 
January 2020 months. Although the 2020 monthly average is 42, the range extends from 34 to 53. 
The average so far for 2021 is 51, and the range is 42 to 59.
Figure 2: Number of suspected and confirmed fatal overdoses by month
3
July 2021  Maine Monthly Overdose Report
Table 2 shows the frequency distribution of deaths at the county level. The July 2021 totals can 
be compared either to the percentage of the census population on the far left or the percentage 
of all Maine drug deaths for 2019, 2020, and January–July 2021. Caution must be exercised with 
the small numbers for a single month. They may fluctuate randomly, without any significant 
statistical meaning.
The cumulative percentages of deaths for many counties for 2021 (January–July) fall within 0%–
1% of the 2019 census distribution, including those of Franklin, Knox, Lincoln, and Piscataquis. 
Counties that are 2% or more higher than the census proportions include Androscoggin (+3%), 
Hancock (+2%), Kennebec (+2%), Oxford (+2%), Penobscot (+3%) and Waldo (+2%). Counties that 
are 2% or more lower than the census proportion include Cumberland (-9%), Somerset (-2%) 
and York (-3%).
The cumulative January–June 2021 percentages stayed the same from June to July for most 
counties. However, between June and July there was a significant increase for Penobscot County 
and a corresponding decrease for Cumberland County, as well as a slight increase for Kennebec, 
Piscataquis, Sagadahoc, Somerset, and York. Cumberland County, with 22% of the census 
population, had 26% of the drug deaths in 2019, 19% in 2020, 17% January through July 2021, and 
12% in July alone. By contrast, Penobscot County, with 11% of the census population, had 14% of 
the drug deaths in 2019, 19% in 2020, 17% January through June 2021, and 25% of the July drug 
deaths.












July 2021  
Est. N=52
Androscoggin 8% 33 (9%) 52 (10%) 42 (12%) 2 (4%)
Aroostook 5% 14 (4%) 17 (3%) 16 (5%) 3 (6%)
Cumberland 22% 100 (26%) 97 (19%) 61 (17%) 6 (12%)
Franklin 2% 5 (1%) 8 (2%) 6 (2%) 1 (2%)
Hancock 4% 9 (2%) 13 (3%) 13 (4%) 1 (2%)
Kennebec 9% 42 (10%) 49 (10%) 41 (12%) 7 (14%)
Knox 3% 7 (2%) 16 (3%) 7 (2%) 2 (4%)
Lincoln 3% 11 (3%) 9 (2%) 13 (4%) 2 (4%)
Oxford 4% 9 (2%) 15 (3%) 15 (4%) 1 (2%)
Penobscot 11% 53 (14%) 94 (19%) 60 (17%) 13 (25%)
Piscataquis 1% 3 (1%) 10 (2%) 5 (1%) 2 (4%)
Sagadahoc 3% 8 (2%) 8 (2%) 4 (1%) 1 (2%)
Somerset 4% 16 (4%) 13 (3%) 8 (2%) 3 (3%)
Waldo 3% 3 (1%) 9 (2%) 9 (3%) 0 (0%)
Washington 2% 10 (3%) 20 (4%) 13 (4%) 0 (0%)
York 15% 57 (15%) 74 (15%) 44 (12%) 8 (15%)
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Table 3 displays the age and gender composition of the monthly confirmed and suspected 
fatal overdose population. The cumulative proportion of males has stayed roughly the same 
since 2019. In the first six months of 2021, it was 217 (70%), which is slightly lower than 71% in 
2020 and slightly higher than the 68% in 2019. In July it declined to 58%. The cumulative age 
distribution in January–July 2021 compared to 2019 has likewise stayed roughly similar. The 
percentage of those 18–39 decreased overall by 3%. The percentage of those 40–59 and those 
over 60 rose by 2% and 1% respectively. 
During January through July 2021, out of 357 confirmed and suspected fatal overdoses for 
which race was reported, 327 (92%) of the victims were identified as White, 17 (5%) as Black 
or African American, and 10 (3%) as American Indian/Alaska Native. Out of 352 for which 
Hispanic ethnicity status was reported, 349 (99%) were reported as not Hispanic, and 3 (1%) 
were identified as Hispanic. Out of the 357 cases, 23 (6%) were identified as having a military 
background. Prior overdose history was reported for 119 (33%) of the victims. Transient housing 
status was reported for 29 (8%) of the victims.







Jan–July 2021  
Est. N=357
July 2021  
Est. N=52
Males 258 (68%) 357 (71%) 244 (68%) 30 (58%)
Under 18 0 (0%) 2 (<1%) 2 (1%) 0 (0%)
18–39 171 (45%) 213 (42%) 144 (40%) 22 (42%)
40–59 175 (46%) 235 (47%)  172 (48%) 25 (48%)
60+ 33 (9%) 54 (11%) 39 (11%) 5 (10%)
Table 4 reports some of the basic incident patterns. Roughly similar to 2020, during 
January through July of 2021, both EMS and police responded to most fatal overdoses, 76%. 
Law enforcement was more likely to respond to a scene alone (19%) than EMS (5%). The 
overwhelming majority (96%) of drug overdoses were ruled as accidental manner of death. 
During January through July of this year, 38% of cases had naloxone administered at the scene 
or in the ambulance, whether by EMS, bystanders, or law enforcement. In 2020, that percentage 
was 33%. This increase may be due to the greater availability of police trained to administer 
it through programs like the Attorney General’s Naloxone Distribution Initiative. It may also 
be due to the greater availability in the community due to the Maine Naloxone Distribution 
Initiative. Although most cases had bystanders present at the scene when first responders 
arrived, the details about who may have been present at the time of the overdose were usually 
unclear. No one experiencing an overdose in July had a known naloxone prescription, but 7 did 
in 2020 and 4 for January through June this year.
Based on 289 suspected or confirmed drug death cases with EMS involvement during January 
to July, 136 (47%) victims were already deceased when EMS arrived. Of the remaining 153 (53%), 
resuscitation was attempted either at the scene or in the ambulance during transport to the 
emergency room. Of the 153 cases who were still alive when EMS arrived, 49 were transported, 
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and 104 did not survive to be transported. Thus, out of 289 fatal cases with EMS response, only 
49 (17%) remained alive long enough to be transported but died during transport or at the 
emergency room.







July 2021 Est. 
N=52
Manner of death (suspected or confirmed)
Accident 457 (91%) 344 (96%) 51 (98%)
Suicide 33 (7%) 9 (3%) 1 (2%)
Undetermined 14 (3%) 4 (1%) 0 (0%)
First Responder
EMS response alone 28 (6%) 16 (5%) 4 (8%)
Law enforcement alone 107 (21%) 67 (19%) 7 (14%)
EMS and law enforcement 365 (72%) 273 (77%) 40 (77%)
Naloxone Administration
Naloxone administration at scene and/or (presumably) 
in ambulance during transport to emergency room
127 (33%) 135 (38%) 19 (37%)
Naloxone administration reported at the scene 83 (22%) 112 (31%) 14 (27%)
Bystander only administered 11 (2%) 22 (6%) 4 (8%)
Law enforcement only administered 8 (2%) 13 (4%) 0 (0%)
EMS only administered 55 (11%) 51 (14%) 6 (12%)
EMS and law enforcement administered 4 (1%) 16 (5%) 2 (4%)
EMS and bystander administered 8 (2%) 8 (2%) 1 (2%)
Law enforcement and bystander administered 0 (0%) 2 (<1%) 1 (2%)
EMS, bystander, and law enforcement administered - 1 (<1%) 0 (0%)
Table 5 displays the frequencies of the most prominent drug categories causing death among 
confirmed drug deaths. As expected, nonpharmaceutical fentanyl was the most frequent cause 
of death so far for 2021 at 232 (77%), a full 10% higher than in 2020 (67%). 
Fentanyl is nearly always found in combination with multiple other drugs. Illicit stimulants have 
been increasingly mentioned as co-intoxicants of fentanyl during the past several years. Heroin 
involvement, declining each year, was reported as a cause in 6% of 2021 deaths, compared to 
11% last year. Methamphetamine was cited as a cause in 25% of the overdoses, which is 5% more 
than in 2020. Cocaine-involved fatalities January–July constituted 22% of cases, slightly less 
than the 23% in 2020. Fentanyl is found in combination with cocaine in 19% of 2021 cases, and in 
combination with methamphetamine in 19%. Xylazine and nonpharmaceutical tramadol were 
identified as co-intoxicants with fentanyl for the first time in 2021. Among 302 confirmed deaths 
caused by fentanyl January–July, the number and percent of cases with xylazine listed as an 
additional cause of death is 30 (10%) of confirmed overdose deaths, and 15 (5%) with tramadol 
listed as one of the causes of death. 
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Table 5:  Key drug categories and combinations causing death among confirmed overdoses
Cause of death  
(alone or in combination with other drugs)  






July 2021  
N=10***
Nonpharmaceutical opioids
Fentanyl or fentanyl analogs 336 (67%) 232 (77%) 8 (80%)
Heroin 57 (11%) 17 (6%) 2 (20%)
Nonpharmaceutical stimulants
Cocaine 118 (23%) 65 (22%) 3 (30%)
Methamphetamine 99 (20%) 74 (25%) 1 (10%)
Pharmaceutical opioids** 118 (23%) 69 (23%) 3 (30%)
Key combinations
Fentanyl and heroin 47 (9%)     21 (6%) 2 (20%)
Fentanyl and cocaine 97 (19%) 56 (19%) 3 (30%)
Fentanyl and methamphetamine 70 (14%) 58 (19%) 1 (10%)
Fentanyl and xylazine 0 (0%) 30 (10%) 1 (10%)
Fentanyl and tramadol 0 (0%) 15 (5%) 0 (0%)
**Nonpharmaceutical tramadol is now being combined with fentanyl in pills and powders for illicit drug use. When 
found in combination with fentanyl, and in the absence of a known prescription, tramadol is no longer counted as a 
pharmaceutical opioid.
***Only 10 July cases out of 52 were completed at the time this report. The totals for each of these categories are too 
small to be statistically meaningful.
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Highlight of the Month Regarding 
Substance Use Disorder Public Policy Response
Department of Corrections Efforts to Provide Medically Assisted Treatment to 
All Residents in DOC Custody
In 2019 the Department of Corrections (DOC) began its pilot to provide Medically Assisted Treatment 
(MAT) to all residents in their custody.  Since implementing the MAT pilot, the program has provided 
MAT to over 1200 residents, with 780 of the residents being released with continuity of care plans in 
place following discharge.  It is anticipated that 800 current residents could be receiving treatment 
by the end of the year, as the intent is to have MAT universally available to any adult with a Substance 
Use Disorder (SUD) diagnosis, regardless of the length of their sentence.  That this effort grew during 
the global pandemic, at a time when many of the county jail programs were contracting, is a credit 
to Commissioner Liberty, Deputy Commissioner Thornell and the entire DOC team.  They presented 
a breakout session on the program at the July 15 Governor’s Opioid Summit. 
There is currently a strong effort to get contracts in place to assist the jail medical/MAT providers. 
The State is furnishing Narcan to residents when they are released by the DOC, as well as by a number 
of jails.  For example, Aroostook County Sheriff Gillen and his staff and medical/MAT team has 
provided MAT services to 151 residents in the jail in the previous 12 months (during the pandemic). 
They currently have 32 inmates on MAT.
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Background Information about this Report
This report, funded jointly by the Maine Office of Attorney General and the Office of Behavioral Health1, 
provides an overview of statistics regarding suspected and confirmed fatal and nonfatal drug overdoses 
in Maine during the month of March 2021. Data for the fatal overdoses were collected at the Office of Chief 
Medical Examiner and data regarding non-fatal overdoses were contributed by the Maine CDC, Maine 
Emergency Management Services, Maine ODMAP initiative, Maine Naloxone Distribution Initiative, and 
Office of Attorney General Naloxone Distribution. Monthly reports are designed to improve transparency 
and timeliness regarding Maine’s epidemic of substance use morbidity and mortality. Year-to-date 
numbers are updated with each monthly report, as medical examiner cases are finalized, and their overdose 
status is confirmed or ruled out. The totals are expected to shift as case completion occurs. In addition, due 
to the small sample size in each month, we expect totals to fluctuate from month to month due to the effects 
of random variation. The monthly reports will be posted on mainedrugdata.org.
A “drug death” is confirmed when one or more drugs are mentioned on the death certificate as a cause 
significant contributing factor for the death. Most drug-induced fatalities are accidents related primarily 
to drug lethality, the unique vulnerability of the drug user, such as underlying medical conditions, and the 
particular circumstances surrounding drug use during that moment. 
A “suspected” drug fatality is identified by physiological signs of overdose as well as physical signs at the 
scene and witness information. In order to be confirmed as a drug death, the medical examiner must 
have issued a final death certificate which includes the names of the specific drugs. A forensic toxicology 
exam must also have been done, which includes a minimum of two toxicology tests, one to screen for drugs 
present, and another that will quantify the levels of drugs in the decedent’s system. All cases receive a 
thorough external examination. In some cases a complete autopsy is also done. Additional data, such as 
medical records and police incident reports are also collected. Most cases are completed within one month.
By highlighting drug death at the monthly level, this report brings attention to the often dramatic shifts in 
totals that can occur from month to month. These fluctuations are common with small numbers, and will 
tend toward an average over time. Whereas the overall number of overdose deaths is a critical indicator of 
individual and societal stress, this metric itself can be quite resistant to public policy interventions due to 
its complexity. Overdose fatalities occur because of multiple unique and interacting factors, as mentioned 
above. For that reason, these reports will seek to monitor components that can be directly affected by specific 
public health education and harm reduction interventions. Maine Monthly Overdose Report
1 The Office of Attorney General supports ongoing research on fatal overdoses by the University of Maine. Additionally, the 
Overdose Data to Action cooperative agreement from the U.S. Centers for Disease Control also provides funding to the State 
of Maine’s Office of Behavioral Health and Center for Disease Control, which support university programs involving fatal 
and non-fatal overdoses, and enable collection of data included in this report. The conclusions represented here do not 
necessarily represent those of the U.S. CDC.
